Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT - Abstract

Departments of Radiology, Urology, and Pathology & Laboratory Medicine, Emory University, Atlanta, GA.


Prostate carcinoma is the second most common cause of cancer-related mortality in males in the United States. The pattern of metastatic disease of prostate cancer is well recognized, frequently involving sclerotic bone lesions and abdominopelvic lymph nodes. Anti-3 F-18 FACBC acid is a synthetic amino acid analog positron emission tomography radiotracer with reported utility in the detection of prostate carcinoma. We present 2 cases of unusual presentations of prostate carcinoma, one with malignant ascites and omental implants and the other with lytic bone lesions detected with anti-3 F-18 FACBC acid.

Written by:
Amzat R, Taleghani P, Savir-Baruch B, Nieh PT, Master VA, Halkar RK, Lewis MM, Faurot M, Bellamy LM, Goodman MM, Schuster DM.   Are you the author?

Reference: Clin Nucl Med. 2011 Sep;36(9):800-2.
doi: 10.1097/RLU.0b013e318219b47e

PubMed Abstract
PMID: 21825855

UroToday.com Prostate Cancer Section